AI assistant
Acumen Pharmaceuticals, Inc. — Director's Dealing 2021
Jul 8, 2021
34208_dirs_2021-07-08_a4fabe0d-8352-450b-8fea-a6f9d2f9bc40.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Acumen Pharmaceuticals, Inc. (ABOS)
CIK: 0001576885
Period of Report: 2021-07-06
Reporting Person: Sands Capital Ventures Discovery Fund III, L.P. (10% Owner)
Reporting Person: Sands Capital Global Venture Fund II, L.P. (10% Owner)
Reporting Person: Sands Capital Life Sciences Pulse Fund, LLC (10% Owner)
Reporting Person: SANDS FRANK M. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-06 | Common Stock | C | 1124729 | — | Acquired | 1124729 | Direct |
| 2021-07-06 | Common Stock | C | 1842346 | — | Acquired | 2967075 | Direct |
| 2021-07-06 | Common Stock | P | 450000 | $14.88 | Acquired | 3417075 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-06 | Series A-1 Preferred Stock | $ | C | 1124729 | Disposed | Common Stock (1124729) | Direct | |
| 2021-07-06 | Series B Preferred Stock | $ | C | 1842346 | Disposed | Common Stock (1842346) | Direct |
Footnotes
F1: Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering.
F2: Represents 225,000 shares of Common Stock acquired by Sands Capital Global Venture Fund II, L.P. ("Sands Venture Fund") and 225,000 shares of Common Stock acquired by ands Capital Life Sciences Pulse Fund ("Sands Pulse Fund") in connection with the closing of the Issuer's initial public offering.
F3: Consists of 1,124,719 shares of Common Stock held by Sands Capital Ventures Discovery Fund III, L.P. ("Sands Discovery Fund "). Sands Capital Ventures Discovery Fund III-GP, LLC ("Sands Discovery GP") is the general partner of Sands Discovery Fund. Sands Discovery GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F4: Consists of 921,173 shares of Common Stock held by Sands Venture Fund and 921,173 shares of Common Stock held by Sands Pulse Fund. Sands Capital Global Venture Fund II-GP, L.P. ("Sands Venture GP L.P.") is the general partner of Sands Venture Fund and Sands Capital Global Venture Discovery Fund II-GP, LLC ("Sands Venture GP LLC") is the general partner of Sands Venture GP L.P. Sands Venture GP L.P. and Sands Venture GP LLC each disclaims beneficial ownership of such securities except to the extent of its respective pecuniary interest therein.
F5: Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.